Sentinel Lymph Node Biopsy Procedures.

Area of Science:

• Oncology
• Surgical Pathology
• Cancer Staging

Background:

• Accurate cancer staging, particularly lymph node assessment, is crucial for treatment but often involves invasive procedures with significant morbidity.
• Traditional methods require excising multiple lymph nodes, leading to complications.
• The sentinel lymph node concept offers a less invasive alternative for staging.

Purpose of the Study:

• To review the current status and clinical trial results of sentinel lymph node biopsy (SLNB) procedures for various cancers.
• To evaluate the success and practicality of SLNB in different oncological settings.
• To provide an overview of SLNB applications in breast, melanoma, head and neck, gastrointestinal, genitourinary, and gynecological cancers.

Main Methods:

• Literature review of sentinel lymph node biopsy (SLNB) procedures.
• Analysis of clinical trial data for SLNB in various cancer types.
• Discussion of the evolution and refinement of the sentinel lymph node concept.

Main Results:

• SLNB is routinely used for breast, melanoma, head and neck, and penile cancers.
• Ongoing investigations are exploring SLNB for other cancers, with varying degrees of success and practicality.
• The review covers SLNB applications in gastric, esophageal, colon, prostate, uterine, cervical, vulvar, and ovarian cancers.

Conclusions:

• Sentinel lymph node biopsy (SLNB) is a valuable tool for accurate cancer staging with reduced morbidity.
• Continued research and clinical trials are essential to expand the utility of SLNB to a broader range of cancers.
• SLNB represents a significant advancement in minimizing surgical complications while maintaining staging accuracy.